Skip to main content
Top
Published in: BMC Cancer 1/2013

Open Access 01-12-2013 | Research article

A population-based cross-sectional study of colorectal cancer screening practices of first-degree relatives of colorectal cancer patients

Authors: Ryan J Courtney, Christine L Paul, Mariko L Carey, Robert W Sanson-Fisher, Finlay A Macrae, Catherine D’Este, David Hill, Daniel Barker, Jody Simmons

Published in: BMC Cancer | Issue 1/2013

Login to get access

Abstract

Background

The aim of this study was to determine the proportions and predictors of first-degree relatives (FDRs) of colorectal cancer (CRC) patients (i) ever receiving any CRC testing and (ii) receiving CRC screening in accordance with CRC screening guidelines.

Methods

Colorectal cancer patients and their FDRs were recruited through the population-based Victorian Cancer Registry, Victoria, Australia. Seven hundred and seven FDRs completed telephone interviews. Of these, 405 FDRs were deemed asymptomatic and eligible for analysis.

Results

Sixty-nine percent of FDRs had ever received any CRC testing. First-degree relatives of older age, those with private health insurance, siblings and FDRs who had ever been asked about family history of CRC by a doctor were significantly more likely than their counterparts to have ever received CRC testing. Twenty-five percent of FDRs “at or slightly above average risk” were adherent to CRC screening guidelines. For this group, adherence to guideline-recommended screening was significantly more likely to occur for male FDRs and those with a higher level of education. For persons at “moderately increased risk” and “potentially high risk”, 47% and 49% respectively adhered to CRC screening guidelines. For this group, guideline-recommended screening was significantly more likely to occur for FDRs who were living in metropolitan areas, siblings, those married or partnered and those ever asked about family history of CRC.

Conclusions

A significant level of non-compliance with screening guidelines was evident among FDRs. Improved CRC screening in accordance with guidelines and effective systematic interventions to increase screening rates among population groups experiencing inequality are needed.

Trial Registration

Australian and New Zealand Clinical Trial Registry: ACTRN12609000628246
Appendix
Available only for authorised users
Literature
2.
go back to reference Alketruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewie DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK: National cancer institute. Surveillance epidemiology and End results. Cancer statistics review. 1975-2007. http://seer.cancer.gov/csr/1975_2007/. Alketruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewie DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK: National cancer institute. Surveillance epidemiology and End results. Cancer statistics review. 1975-2007. http://​seer.​cancer.​gov/​csr/​1975_​2007/​.
3.
go back to reference Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F: Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. N Engl J Med. 1993, 328: 1365-1371. 10.1056/NEJM199305133281901.CrossRefPubMed Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F: Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. N Engl J Med. 1993, 328: 1365-1371. 10.1056/NEJM199305133281901.CrossRefPubMed
4.
go back to reference Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O: Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet. 1996, 348: 1467-1471. 10.1016/S0140-6736(96)03430-7.CrossRefPubMed Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O: Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet. 1996, 348: 1467-1471. 10.1016/S0140-6736(96)03430-7.CrossRefPubMed
5.
go back to reference Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM: Randomised controlled trial of fecal occult blood screening for colorectal cancer. Lancet. 1996, 348: 1472-1477. 10.1016/S0140-6736(96)03386-7.CrossRefPubMed Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM: Randomised controlled trial of fecal occult blood screening for colorectal cancer. Lancet. 1996, 348: 1472-1477. 10.1016/S0140-6736(96)03386-7.CrossRefPubMed
6.
go back to reference Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM: The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000, 343: 1603-1607. 10.1056/NEJM200011303432203.CrossRefPubMed Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM: The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000, 343: 1603-1607. 10.1056/NEJM200011303432203.CrossRefPubMed
7.
go back to reference Ananda SS, McLauglin SJ, Chen F, Hayes IP, Hunter AA, Skinner IJ, Steel MC, Jones IT, Hastie IA, Rieger NA, Shedda S, Compston DJ, Gibbs P: Initial impact of Australia's national bowel cancer screening program. Med J Aust. 2009, 191: 378-381.PubMed Ananda SS, McLauglin SJ, Chen F, Hayes IP, Hunter AA, Skinner IJ, Steel MC, Jones IT, Hastie IA, Rieger NA, Shedda S, Compston DJ, Gibbs P: Initial impact of Australia's national bowel cancer screening program. Med J Aust. 2009, 191: 378-381.PubMed
8.
go back to reference Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M: Protection from colorectal cancer after colonoscopy: a population based case control study. Ann Inten Med. 2011, 154: 22-30.CrossRef Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M: Protection from colorectal cancer after colonoscopy: a population based case control study. Ann Inten Med. 2011, 154: 22-30.CrossRef
9.
go back to reference Ransohoff DF: How much does colonoscopy reduce colon cancer mortality?. Ann Intern Med. 2009, 150: 50-52.CrossRefPubMed Ransohoff DF: How much does colonoscopy reduce colon cancer mortality?. Ann Intern Med. 2009, 150: 50-52.CrossRefPubMed
10.
go back to reference Crespi M, Stigliano V, Assisi D: Current trends and secondary prevention of colorectal cancer. Hepatogastroenterology. 2001, 48: 1635-1640.PubMed Crespi M, Stigliano V, Assisi D: Current trends and secondary prevention of colorectal cancer. Hepatogastroenterology. 2001, 48: 1635-1640.PubMed
11.
go back to reference Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF: Prevention of colorectal cancer by colonoscopic polypectomy. The national polyp study workgroup. N Engl J Med. 1993, 329: 1977-1981. 10.1056/NEJM199312303292701.CrossRefPubMed Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF: Prevention of colorectal cancer by colonoscopic polypectomy. The national polyp study workgroup. N Engl J Med. 1993, 329: 1977-1981. 10.1056/NEJM199312303292701.CrossRefPubMed
12.
go back to reference Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, Woolf SH, Glick SN, Ganiats TG, Bond JH, Rosen L, Zapka JG, Olsen SJ, Giardiello FM, Sisk JE, VanAntwerp R, Borwn-Davis C, Marciniak DA, Mayer RJ: Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997, 112: 594-642. 10.1053/gast.1997.v112.agast970594.CrossRefPubMed Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, Woolf SH, Glick SN, Ganiats TG, Bond JH, Rosen L, Zapka JG, Olsen SJ, Giardiello FM, Sisk JE, VanAntwerp R, Borwn-Davis C, Marciniak DA, Mayer RJ: Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997, 112: 594-642. 10.1053/gast.1997.v112.agast970594.CrossRefPubMed
14.
go back to reference St John DJB, McDermott FT, Hopper JL, Debney EA, Johnson WR, Hughes ES: Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med. 1993, 118: 785-790.CrossRefPubMed St John DJB, McDermott FT, Hopper JL, Debney EA, Johnson WR, Hughes ES: Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med. 1993, 118: 785-790.CrossRefPubMed
15.
go back to reference Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, Lynch P, Burke W, Press N: Recommendations for the care of individuals with inherited predisposition to Lynch Syndrome. JAMA. 2006, 296: 1507-1517. 10.1001/jama.296.12.1507.CrossRefPubMed Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, Lynch P, Burke W, Press N: Recommendations for the care of individuals with inherited predisposition to Lynch Syndrome. JAMA. 2006, 296: 1507-1517. 10.1001/jama.296.12.1507.CrossRefPubMed
16.
go back to reference Pariente A, Milan C, Lafon J, Faivre J: Colonoscopic screening in first-degree relatives of patients with 'sporadic' colorectal cancer: a case-control study. Gastroenterology. 1998, 115: 7-12. 10.1016/S0016-5085(98)70358-0.CrossRefPubMed Pariente A, Milan C, Lafon J, Faivre J: Colonoscopic screening in first-degree relatives of patients with 'sporadic' colorectal cancer: a case-control study. Gastroenterology. 1998, 115: 7-12. 10.1016/S0016-5085(98)70358-0.CrossRefPubMed
17.
go back to reference Boultron MC, Faivre J, Quipourt V, Senesse P, Michaels C: Family history of colorectal tumours and implications for the adenoma-carcinoma sequence: a case-control study. Gut. 1995, 37: 830-834. 10.1136/gut.37.6.830.CrossRef Boultron MC, Faivre J, Quipourt V, Senesse P, Michaels C: Family history of colorectal tumours and implications for the adenoma-carcinoma sequence: a case-control study. Gut. 1995, 37: 830-834. 10.1136/gut.37.6.830.CrossRef
20.
go back to reference United States Preventive Services Task Force: Screening for colorectal cancer: U.S. Preventive services task force recommendation statement. Ann Inten Med. 2008, 149: 627-637.CrossRef United States Preventive Services Task Force: Screening for colorectal cancer: U.S. Preventive services task force recommendation statement. Ann Inten Med. 2008, 149: 627-637.CrossRef
21.
go back to reference Longacre AV, Cramer LD, Gross CP: Screening colonoscopy use among individuals at higher colorectal cancer risk. J Clin Gastroenterol. 2006, 40: 490-496. 10.1097/00004836-200607000-00006.CrossRefPubMed Longacre AV, Cramer LD, Gross CP: Screening colonoscopy use among individuals at higher colorectal cancer risk. J Clin Gastroenterol. 2006, 40: 490-496. 10.1097/00004836-200607000-00006.CrossRefPubMed
22.
go back to reference Ramji F, Cotterchio M, Manno M, Rabeneck L, Gallinger S: Association between subjects factors and colorectal cancer screening participation in Ontario, Canada. Cancer Detect Prev. 2005, 29: 221-226. 10.1016/j.cdp.2005.04.001.CrossRefPubMed Ramji F, Cotterchio M, Manno M, Rabeneck L, Gallinger S: Association between subjects factors and colorectal cancer screening participation in Ontario, Canada. Cancer Detect Prev. 2005, 29: 221-226. 10.1016/j.cdp.2005.04.001.CrossRefPubMed
23.
go back to reference Rees G, Martin PR, Macrae FA: Screening participation in individuals with a family history of colorectal cancer: a review. Eur J Cancer Care. 2008, 17: 221-232. 10.1111/j.1365-2354.2007.00834.x.CrossRef Rees G, Martin PR, Macrae FA: Screening participation in individuals with a family history of colorectal cancer: a review. Eur J Cancer Care. 2008, 17: 221-232. 10.1111/j.1365-2354.2007.00834.x.CrossRef
24.
go back to reference Courtney RJ, Paul CL, Sanson-Fisher RW, Macrae FA, Carey ML, Attia J, McEvoy M: Colorectal cancer screening in Australia: a community-level perspective. Med J Aust. 2011, 196: 516-520.CrossRef Courtney RJ, Paul CL, Sanson-Fisher RW, Macrae FA, Carey ML, Attia J, McEvoy M: Colorectal cancer screening in Australia: a community-level perspective. Med J Aust. 2011, 196: 516-520.CrossRef
25.
go back to reference Armelao F, Orlandi PG, Tasini E, Franceschini G, Franch R, Paternolli C, de Pretis G: High uptake of colonoscopy in first-degree relatives of patients with colorectal cancer in a healthcare region: a population-based, prospective study. Endoscopy. 2010, 42: 15-21. 10.1055/s-0029-1215324.CrossRefPubMed Armelao F, Orlandi PG, Tasini E, Franceschini G, Franch R, Paternolli C, de Pretis G: High uptake of colonoscopy in first-degree relatives of patients with colorectal cancer in a healthcare region: a population-based, prospective study. Endoscopy. 2010, 42: 15-21. 10.1055/s-0029-1215324.CrossRefPubMed
26.
go back to reference Bujanda L, Sarasqueta C, Zubiaurre L, Cosme A, Munoz C, Sanchez A, Martin C, Tito L, Pinol V, Castells A, Llor X, Xicola RM, Pons E, Clofent J, De Castro ML, Cuquerella J, Medina E, Gutierrez A, Arenas JI, Jover R: Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer. Gut. 2007, 56: 1714-1718. 10.1136/gut.2007.120709.CrossRefPubMedPubMedCentral Bujanda L, Sarasqueta C, Zubiaurre L, Cosme A, Munoz C, Sanchez A, Martin C, Tito L, Pinol V, Castells A, Llor X, Xicola RM, Pons E, Clofent J, De Castro ML, Cuquerella J, Medina E, Gutierrez A, Arenas JI, Jover R: Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer. Gut. 2007, 56: 1714-1718. 10.1136/gut.2007.120709.CrossRefPubMedPubMedCentral
27.
go back to reference Ruthotto F, Papendorf F, Wegener G, Unger G, Dlugosch B, Korangy F, Manns MP, Greten TF: Participation in screening colonoscopy in first-degree relatives from patients with colorectal cancer. Ann Oncol. 2007, 18: 1518-1522. 10.1093/annonc/mdm200.CrossRefPubMed Ruthotto F, Papendorf F, Wegener G, Unger G, Dlugosch B, Korangy F, Manns MP, Greten TF: Participation in screening colonoscopy in first-degree relatives from patients with colorectal cancer. Ann Oncol. 2007, 18: 1518-1522. 10.1093/annonc/mdm200.CrossRefPubMed
28.
go back to reference Harris MA, Byles JE: A survey of screening compliance among first-degree relatives of people with colon cancer in New South Wales. ANZ J Public Health. 1997, 4: 29-34. Harris MA, Byles JE: A survey of screening compliance among first-degree relatives of people with colon cancer in New South Wales. ANZ J Public Health. 1997, 4: 29-34.
29.
go back to reference Manne S, Markowitz A, Winawer S, Meropol NJ, Haller D, Rakowski W, Babb J, Jandorf L: Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer. Health Psychol. 2002, 21: 3-15.CrossRefPubMed Manne S, Markowitz A, Winawer S, Meropol NJ, Haller D, Rakowski W, Babb J, Jandorf L: Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer. Health Psychol. 2002, 21: 3-15.CrossRefPubMed
30.
go back to reference Thrasher JF, Cummings M, Michalek AM, Mahoney MC, Moysich KB, Pillittere DM: Colorectal cancer screening among individuals with and without a family history. J Public Health Manag Pract. 2002, 8: 1-9.CrossRefPubMed Thrasher JF, Cummings M, Michalek AM, Mahoney MC, Moysich KB, Pillittere DM: Colorectal cancer screening among individuals with and without a family history. J Public Health Manag Pract. 2002, 8: 1-9.CrossRefPubMed
31.
go back to reference Ait Ouakrim D, Boussioutas A, Lockett T, Winship I, Giles GG, Flander LB, Keogh L, Hopper JL, Jenkins MA: Screening practices of unaffected people at familial risk of colorectal cancer. Cancer Prev Res. 2012, 5: 240-247. 10.1158/1940-6207.CAPR-11-0229.CrossRef Ait Ouakrim D, Boussioutas A, Lockett T, Winship I, Giles GG, Flander LB, Keogh L, Hopper JL, Jenkins MA: Screening practices of unaffected people at familial risk of colorectal cancer. Cancer Prev Res. 2012, 5: 240-247. 10.1158/1940-6207.CAPR-11-0229.CrossRef
32.
go back to reference Group EQ: EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990, 16: 199-208.CrossRef Group EQ: EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990, 16: 199-208.CrossRef
33.
go back to reference Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al: Screening and surveillance of the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the american cancer society, the US multi-society task force on colorectal cancer, and the american college of radiology. CA Cancer J Clin. 2008, 58: 130-160. 10.3322/CA.2007.0018.CrossRefPubMed Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al: Screening and surveillance of the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the american cancer society, the US multi-society task force on colorectal cancer, and the american college of radiology. CA Cancer J Clin. 2008, 58: 130-160. 10.3322/CA.2007.0018.CrossRefPubMed
34.
go back to reference Canadian Task Force on Preventive Health Care: Colorectal cancer screening. Recommendation statement from the canadian task force on preventive health care. CMAJ. 2001, 165: 206-208. Canadian Task Force on Preventive Health Care: Colorectal cancer screening. Recommendation statement from the canadian task force on preventive health care. CMAJ. 2001, 165: 206-208.
35.
go back to reference Cockburn J, Paul C, Tzelepis F, McElduff , Byles J: Screening for bowel cancer among NSW adults with varying levels of risk: a community survey. ANZ J Public Health. 2002, 26: 236-241. Cockburn J, Paul C, Tzelepis F, McElduff , Byles J: Screening for bowel cancer among NSW adults with varying levels of risk: a community survey. ANZ J Public Health. 2002, 26: 236-241.
36.
go back to reference Weber MF, Banks E, Ward R, Sitas F: Population characteristics related to colorectal cancer testing in New South Wales, Australia: results from the 45 and Up Study cohort. J Med Screening. 2008, 15: 137-142. 10.1258/jms.2008.008050.CrossRef Weber MF, Banks E, Ward R, Sitas F: Population characteristics related to colorectal cancer testing in New South Wales, Australia: results from the 45 and Up Study cohort. J Med Screening. 2008, 15: 137-142. 10.1258/jms.2008.008050.CrossRef
37.
go back to reference Murff HJ, Peterson NB, Greevy RA, Shrubsole MJ, Zheng W: Early initiation of colorectal cancer screening in individuals with affected first-degree relatives. J Gen Intern Med. 2007, 22: 121-126. 10.1007/s11606-007-0115-6.CrossRefPubMedPubMedCentral Murff HJ, Peterson NB, Greevy RA, Shrubsole MJ, Zheng W: Early initiation of colorectal cancer screening in individuals with affected first-degree relatives. J Gen Intern Med. 2007, 22: 121-126. 10.1007/s11606-007-0115-6.CrossRefPubMedPubMedCentral
38.
go back to reference Richardson JL, Danley K, Mondrus GT, Deapen D, Mack T: Adherence to screening examinations after diagnosis in a 1st-degree relative. Prev Med. 1995, 24: 166-170. 10.1006/pmed.1995.1030.CrossRefPubMed Richardson JL, Danley K, Mondrus GT, Deapen D, Mack T: Adherence to screening examinations after diagnosis in a 1st-degree relative. Prev Med. 1995, 24: 166-170. 10.1006/pmed.1995.1030.CrossRefPubMed
39.
go back to reference Kinney AY, Choi YA, DeVellis B, Kobetz E, Millikan RC, Sandler RS: Interest in genetic counselling among first-degree relatives of colorectal cancer patients. Am J Prev Med. 2000, 18: 249-252. 10.1016/S0749-3797(99)00162-2.CrossRefPubMed Kinney AY, Choi YA, DeVellis B, Kobetz E, Millikan RC, Sandler RS: Interest in genetic counselling among first-degree relatives of colorectal cancer patients. Am J Prev Med. 2000, 18: 249-252. 10.1016/S0749-3797(99)00162-2.CrossRefPubMed
40.
go back to reference Bastini R, Gallardo NV, Maxwell AE: Barriers to colorectal cancer screening among ethnically diverse high- and average-risk individuals. J Psychosoc Oncol. 2001, 19: 65-84. 10.1300/J077v19n03_06.CrossRef Bastini R, Gallardo NV, Maxwell AE: Barriers to colorectal cancer screening among ethnically diverse high- and average-risk individuals. J Psychosoc Oncol. 2001, 19: 65-84. 10.1300/J077v19n03_06.CrossRef
41.
go back to reference Mack LA, Cook LS, Temple WJ, Carlson LE, Hilsden RJ, Paolucci EO: Colorectal cancer screening among first-degree relatives of colorectal cancer patients: benefits and barriers. Ann Surg Oncol. 2009, 16: 2092-2100. 10.1245/s10434-009-0528-z.CrossRefPubMed Mack LA, Cook LS, Temple WJ, Carlson LE, Hilsden RJ, Paolucci EO: Colorectal cancer screening among first-degree relatives of colorectal cancer patients: benefits and barriers. Ann Surg Oncol. 2009, 16: 2092-2100. 10.1245/s10434-009-0528-z.CrossRefPubMed
42.
go back to reference Javanparast S, Ward P, Young G, Wilson C, Carter S, Misan G, Cole S, Jiwa M, Tsourtos G, Martini A, Gill T, Baratiny G, Matt AM: How equitable are colorectal cancer screening programs which include FOBTs? A review of qualitative and quantitative studies. Prev Med. 2010, 50: 165-172. 10.1016/j.ypmed.2010.02.003.CrossRefPubMed Javanparast S, Ward P, Young G, Wilson C, Carter S, Misan G, Cole S, Jiwa M, Tsourtos G, Martini A, Gill T, Baratiny G, Matt AM: How equitable are colorectal cancer screening programs which include FOBTs? A review of qualitative and quantitative studies. Prev Med. 2010, 50: 165-172. 10.1016/j.ypmed.2010.02.003.CrossRefPubMed
43.
go back to reference Subramanian S, Klosterman MK, Amonkar MM, Hunt TL: Adherence with colorectal cancer screening guidelines: a review. Prev Med. 2004, 38: 536-550. 10.1016/j.ypmed.2003.12.011.CrossRefPubMed Subramanian S, Klosterman MK, Amonkar MM, Hunt TL: Adherence with colorectal cancer screening guidelines: a review. Prev Med. 2004, 38: 536-550. 10.1016/j.ypmed.2003.12.011.CrossRefPubMed
44.
go back to reference Codori AM, Petersen GM, Miglioretti DL, Boyd P: Health beliefs and endoscopic screening for colorectal cancer: potential for cancer prevention. Prev Med. 2001, 33: 128-136.PubMed Codori AM, Petersen GM, Miglioretti DL, Boyd P: Health beliefs and endoscopic screening for colorectal cancer: potential for cancer prevention. Prev Med. 2001, 33: 128-136.PubMed
45.
go back to reference Matthews BA, Anderson RC, Nattinger AB: Colorectal cancer screening behavior and health insurance status. Cancer Causes Control. 2005, 16: 735-742. 10.1007/s10552-005-1228-z.CrossRefPubMed Matthews BA, Anderson RC, Nattinger AB: Colorectal cancer screening behavior and health insurance status. Cancer Causes Control. 2005, 16: 735-742. 10.1007/s10552-005-1228-z.CrossRefPubMed
46.
go back to reference Manne SL, Coups EJ, Winkel G, Markowitz A, Meropol NJ, Lesko SM, Jacobsen PB, Haller D, Jandorf L, Peterson SK: Identifying cluster subtypes for intentions to have colorectal cancer screening among non-compliant intermediate-risk siblings of individuals with colorectal cancer. Health Educ Res. 2009, 24: 897-808. 10.1093/her/cyp043.CrossRefPubMedPubMedCentral Manne SL, Coups EJ, Winkel G, Markowitz A, Meropol NJ, Lesko SM, Jacobsen PB, Haller D, Jandorf L, Peterson SK: Identifying cluster subtypes for intentions to have colorectal cancer screening among non-compliant intermediate-risk siblings of individuals with colorectal cancer. Health Educ Res. 2009, 24: 897-808. 10.1093/her/cyp043.CrossRefPubMedPubMedCentral
47.
go back to reference Madlensky L, Esplen MJ, Gallinger S, McLaughlin JR, Goel V: Relatives of colorectal cancer patients. Factors associated with screening behavior. Am J Prev Med. 2003, 25: 187-194. 10.1016/S0749-3797(03)00202-2.CrossRefPubMed Madlensky L, Esplen MJ, Gallinger S, McLaughlin JR, Goel V: Relatives of colorectal cancer patients. Factors associated with screening behavior. Am J Prev Med. 2003, 25: 187-194. 10.1016/S0749-3797(03)00202-2.CrossRefPubMed
48.
go back to reference Schvartzman P, Rivking E, Neville A, Friger M, Sperber AD: Screening intention and practice among first-degree relatives of colorectal cancer patients in Southern Israel. Israel Medical Association Journal. 2000, 2: 675-678. Schvartzman P, Rivking E, Neville A, Friger M, Sperber AD: Screening intention and practice among first-degree relatives of colorectal cancer patients in Southern Israel. Israel Medical Association Journal. 2000, 2: 675-678.
49.
go back to reference von Euler-Chelpin M, Brasso K, Lynge E: Determinants of participation in colorectal cancer screening with faecal occult blood testing. J Public Health. 2010, 32: 395-405. 10.1093/pubmed/fdp115.CrossRef von Euler-Chelpin M, Brasso K, Lynge E: Determinants of participation in colorectal cancer screening with faecal occult blood testing. J Public Health. 2010, 32: 395-405. 10.1093/pubmed/fdp115.CrossRef
50.
go back to reference Guessous I, Dash C, Lapin P, Doroshenk M, Smith RA, Klabunde CN: Colorectal cancer screening barriers and facilitators in older persons. Prev Med. 2010, 50: 3-10. 10.1016/j.ypmed.2009.12.005.CrossRefPubMed Guessous I, Dash C, Lapin P, Doroshenk M, Smith RA, Klabunde CN: Colorectal cancer screening barriers and facilitators in older persons. Prev Med. 2010, 50: 3-10. 10.1016/j.ypmed.2009.12.005.CrossRefPubMed
51.
go back to reference Beydoun HA, Beydoun MA: Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States. Cancer Causes Control. 2008, 19: 339-359. 10.1007/s10552-007-9100-y.CrossRefPubMed Beydoun HA, Beydoun MA: Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States. Cancer Causes Control. 2008, 19: 339-359. 10.1007/s10552-007-9100-y.CrossRefPubMed
53.
go back to reference Schroy PC, Barrison AF, Ling BS, Wilson S, Geller AC: Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Am J Gastroenterol. 2002, 97: 1031-1036. 10.1111/j.1572-0241.2002.05624.x.CrossRefPubMed Schroy PC, Barrison AF, Ling BS, Wilson S, Geller AC: Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Am J Gastroenterol. 2002, 97: 1031-1036. 10.1111/j.1572-0241.2002.05624.x.CrossRefPubMed
54.
go back to reference Murff HJ, Greevy RA, Syngal S: The comprehensiveness of family cancer history assessments in primary care. Community Genet. 2007, 10: 174-180. 10.1159/000101759.PubMed Murff HJ, Greevy RA, Syngal S: The comprehensiveness of family cancer history assessments in primary care. Community Genet. 2007, 10: 174-180. 10.1159/000101759.PubMed
55.
go back to reference Sifri RD, Wender R, Paynter BS: Cancer risk assessment from family history: gaps in primary care practice. J Fam Pract. 2002, 51: 856-PubMed Sifri RD, Wender R, Paynter BS: Cancer risk assessment from family history: gaps in primary care practice. J Fam Pract. 2002, 51: 856-PubMed
56.
57.
go back to reference Westman J, Hampel H, Bradley T: Efficacy of touchscreen computer based family cancer history questionnaire and subsequent cancer risk assessment. J Med Genet. 2000, 37: 354-360. 10.1136/jmg.37.5.354.CrossRefPubMedPubMedCentral Westman J, Hampel H, Bradley T: Efficacy of touchscreen computer based family cancer history questionnaire and subsequent cancer risk assessment. J Med Genet. 2000, 37: 354-360. 10.1136/jmg.37.5.354.CrossRefPubMedPubMedCentral
58.
go back to reference McLeod RS: Canadian task force on preventive health care. Screening strategies for colorectal cancer: a systematic review of the evidence. Can J Gastroenterol. 2001, 15: 647-660.CrossRefPubMed McLeod RS: Canadian task force on preventive health care. Screening strategies for colorectal cancer: a systematic review of the evidence. Can J Gastroenterol. 2001, 15: 647-660.CrossRefPubMed
59.
go back to reference Delgado-Plasencia L, Lopez-Tomassetti-Fernandez E, Hernandez-Morales A, Torres-Monzon E, Gonzalez-Hermoso F: Willingness to undergo colorectal cancer screening in first-degree relatives of hospitalized patients with colorectal cancer. J Med Screen. 2009, 16: 33-38. 10.1258/jms.2009.008062.CrossRefPubMed Delgado-Plasencia L, Lopez-Tomassetti-Fernandez E, Hernandez-Morales A, Torres-Monzon E, Gonzalez-Hermoso F: Willingness to undergo colorectal cancer screening in first-degree relatives of hospitalized patients with colorectal cancer. J Med Screen. 2009, 16: 33-38. 10.1258/jms.2009.008062.CrossRefPubMed
60.
go back to reference Ziogas A, Anton-Culver H: Validation of family history data in cancer family registries. Am J Prev Med. 2003, 24: 190-198. 10.1016/S0749-3797(02)00593-7.CrossRefPubMed Ziogas A, Anton-Culver H: Validation of family history data in cancer family registries. Am J Prev Med. 2003, 24: 190-198. 10.1016/S0749-3797(02)00593-7.CrossRefPubMed
61.
go back to reference Murff HJ, Spigel DR, Syngal S: Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA. 2004, 12: 1480-1489.CrossRef Murff HJ, Spigel DR, Syngal S: Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA. 2004, 12: 1480-1489.CrossRef
62.
go back to reference Khoja S, McGregor ES, Hilsden RJ: Validation of self-reported history of colorectal cancer screening. Can Fam Physician. 2007, 53: 1192-1197.PubMedPubMedCentral Khoja S, McGregor ES, Hilsden RJ: Validation of self-reported history of colorectal cancer screening. Can Fam Physician. 2007, 53: 1192-1197.PubMedPubMedCentral
63.
go back to reference Baier M, Calonge N, Cutter G, McClatchey M, Schoentgen S, Hines S, Marcus A, Ahnen D: Validity of self reported colorectal cancer screening behaviour. Cancer Epidemiol Biomarkers Prev. 2000, 9: 229-232.PubMed Baier M, Calonge N, Cutter G, McClatchey M, Schoentgen S, Hines S, Marcus A, Ahnen D: Validity of self reported colorectal cancer screening behaviour. Cancer Epidemiol Biomarkers Prev. 2000, 9: 229-232.PubMed
Metadata
Title
A population-based cross-sectional study of colorectal cancer screening practices of first-degree relatives of colorectal cancer patients
Authors
Ryan J Courtney
Christine L Paul
Mariko L Carey
Robert W Sanson-Fisher
Finlay A Macrae
Catherine D’Este
David Hill
Daniel Barker
Jody Simmons
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2013
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-13-13

Other articles of this Issue 1/2013

BMC Cancer 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine